Elevance Health Inc.ANTMNYSE
Loading
ANTM Revenue Growth (YoY Quarterly)•-21.91%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-21.91%
-53.2pp
+0.62%
-16.7pp
-61.27%
-40.0pp
-70.31%
-1672.1pp
-61.03%
-33.0pp
-62.39%
-39.9pp
-63.32%
-41.8pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +77.83% | +33.65% | +30.66% | +31.27% | -21.91% |
| Gross Profit Growth | +22.70% | +20.03% | +16.77% | +17.34% | +0.62% |
| EBITDA Growth | -44.30% | +1869.80% | +1263.94% | -21.22% | -61.27% |
| Operating Income Growth | +5831.62% | +2295.04% | +1456.41% | +1601.74% | -70.31% |
| Net Income Growth | -7.16% | +94.13% | -2.84% | -28.06% | -61.03% |
| EPS Growth | +10.65% | +107.31% | +4.03% | -22.45% | -62.39% |
| EPS Diluted Growth | +13.87% | +109.83% | +5.18% | -21.53% | -63.32% |
| Weighted Average Shares Growth | -100.00% | -0.44% | -0.29% | +0.00% | +0.00% |
| Weighted Average Shares Diluted Growth | -100.00% | -0.86% | -0.41% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -134.23% | -39.17% | -19.17% | -53.71% | +0.00% |
| Free Cash Flow Growth | -154.50% | -38.36% | -21.86% | -64.07% | +0.00% |
| Receivables Growth | -13.64% | -12.04% | -13.65% | +57.38% | +3.70% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +19.20% | +22.84% | +21.42% | +21.75% | +3.94% |
| Book Value per Share Growth | +0.00% | +18.39% | +21.89% | +22.73% | +0.00% |
| Debt Growth | -91.16% | -91.78% | -91.37% | -96.06% | -37.98% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +225.19% | -100.00% | -100.00% | -100.00% | -100.00% |
1 / 4